A defect in the production of interferon has been associated with exacerbation of viral respiratory disease in children' 2 and in animal model systems.3
Respiratory syncytial virus is a major cause of respiratory disease, particularly bronchiolitis, in infants and children. This virus, although sensitive to the action of exogenously applied interferon in tissue culture, is a poor inducer of interferon in human cells.4 5 Interferon concentrations in the nasal secretions of infants, children, and adults with respiratory syncytial virus infection are low when compared with those in the secretions of patients of similar age infected with influenza viruses.69 This allows the suggestion that poor in vivo interferon production may contribute to the susceptibility of infants already compromised by the immaturity of their immune response during a primary respiratory syncytial virus infection. It is noteworthy that parainfluenza virus type 3, which is also associated with bronchiolitis in infants of this age, is also a poor inducer of interferon in vivo.9
In order to test this hypothesis we measured interferon alfa concentrations in the nasopharyngeal secretions of a group of infants with respiratory syncytial virus infection. The association between interferon secretion, the severity of illness, and the degree of virus replication in the upper respiratory tract has been explored. Patients excluded from the analysis.
ASSAY OF INFECTIOUS VIRUS AND INTERFERON IN SECRETIONS
Thawed nasal secretions were diluted in twofold steps in cell maintenance medium and assayed for the presence of infectious virus on microtray monolayers of HeLa cells. At three days postinoculation the monolayers were stained with a pool of subgroup cross reactive antirespiratory syncytial virus monoclonal antibodies'1 and foci of infection were visualised by the immunofluorescence method described by Routledge et al. 12 In parallel an aliquot of secretion was sonicated to disperse mucus and assayed for interferon alfa using an immunoradiometric kit as described by Taylor taken as 2-6 loglo plaque forming units/ml, 1-28 log10 units/ml, and 1-5 log1o units/ml of secretion respectively. For statistical analysis, where assays were negative or titres/ml fell below these values, the titre/ml for the specimen was taken as equivalent to the sensitivity of detection.
Summated yields of infectivity, interferon, and F antigen over the first three days after admission were calculated from the formula:
Xl/Xl1+X2/X2. *****+nX Summated titre X n where xl to n=titre on day 1 to day n and xl to mean titre for specimens for all patients tested on that day. Expression of each value as a fraction of the mean in this way allowed summation where samples from one of the three days was missing. Pairs of coordinates were analysed by product moment and Spearman's rank correlation.
Results
Severity scores were normally distributed around a mean (SD) of 2.55 (0-62). There was no correlation between the age of the infants and the severity of infection.
Measurable quantities of secretion were obtained on at least one of the first three days after admission for 53 of the 54 cases studied. Virus was demonstrable from 30 (57%) of these patients. Mean infectivity titres were highest for the first sample tested falling thereafter so that after three days only two of 32 tested were positive (figure A). Infectivity in the secretions of five infants was followed throughout their stay in hospital. None showed a rise in virus titre after the third day. In a preliminary experiment F protein was assayed in daily nasopharyngeal secretions from six patients throughout their stay in hospital. Mean levels recovered, uncorrected for volume, were similar for three days postinfection but then declined, although four of the six patients still secreted detectable F protein when tested one week after admission. Thirty six patients were tested by the same technique during the first three days after admission. All but two were positive on at least one day. Mean concentrations of F protein/ml of secretion remained essentially constant over three days (figure B). There was a highly significant positive correlation between summated F protein and infectivity titres (table) .
Although interferon was detectable in all but eight of the 54 infants tested only 26 secreted more (table) .
Recovery of infectious virus, F protein, and interferon were negatively correlated with the age of the infants but positively correlated with the clinical severity of infection. In no case, however, did correlations approach significance. It is noteworthy that two infants, 53 and 25 (figure), secreted very high titres of infectious virus together with high concentrations of F protein and interferon. Both were less than 7 weeks old and were among the most severely ill in this study (severity scores 4 0 and 3-38 respectively).
Discussion
It is generally recognised that infants under 1 year of age are most vulnerable to respiratory syncytial virus, that the incidence of bronchiolitis peaks in the second or third month of life and that infants under 1 month of age generally are less severly affected. '6 Despite this appreciable age related variability in the pathogenesis of infection, in the group of infants studied here there was no correlation between age and clinical severity score. This bears out a previous study on a smaller group of patients17 and probably relates to the relative uniformity of the group studied. All of the patients were between 3 and 40 weeks of age and all had been admitted to hospital with respiratory disease later diagnosed as respiratory syncytial virus infection.
The uniformity of the group may also explain why no significant correlation was observed between virus secretion and the age of the infants. Hall et al, '8 19 Interferon secretion showed no significant correlation with clinical assessment of the severity of infection and was positively correlated with both virus infectivity and F protein antigen secretion whereas our hypothesis predicted a negative correlation. This pattern is similar to that found in other primary virus infections of the respiratory tract,20 21 and this suggests that limitations in the secretion of alfa interferons, at least of those species detectable by the YOK-1 monoclonal antibody, do not underly the development of bronchiolitis. That neither interferon, infectivity, nor F protein secretion were significantly associated with clinical severity assessment also diminishes hope that such easily measured variables might assist in prognosis.
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